The Medicines (Marketing Authorisations and Miscellaneous Amendments) Regulations 2004

Amendment of the Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003

This adran has no associated Memorandwm Esboniadol

8.  In the Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003(1), in regulation 1 (citation, commencement and interpretation), in paragraph (2), in paragraph (a)(ii) of the definition of “unlicensed product”, for “the European Agency for the Evaluation of Medicinal Products under” substitute “the European Commission under”.